Pharma Must Unite On MFN Launch Prices To Boost Rates Abroad, CMS’ Brooks Says

 
• By Cathy Kelly
  
Can manufacturers march in lockstep on launch prices? (Shutterstock)

More from Pricing Debate

More from Market Access